Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Sales | 42,736 | 38,419 | 51,741 | 59,731 | 0 |
| Gross Profit | 42,736 | 38,419 | 51,741 | 59,731 | N/A |
| Operating Expenses | 98,204 | 75,642 | 71,013 | 58,367 | 0 |
| Operating Income | -55,468 | -37,223 | -19,272 | 1,364 | N/A |
| Interest Expense | 4,350 | -290 | 689 | 0 | 0 |
| Other Income | 4,074 | 1,616 | 273 | 338 | 0 |
| Pre-tax Income | -55,744 | -35,317 | -19,688 | 1,702 | 0 |
| Net Income Continuous | -55,744 | -35,317 | -19,688 | 1,702 | N/A |
| Net Income | $-55,744 | $-35,317 | $-19,688 | $1,702 | $N/A |
| EPS Basic Total Ops | -24.30 | -61.30 | -439.50 | 41.72 | N/A |
| EPS Basic Continuous Ops | -24.28 | -61.32 | -439.52 | 41.72 | N/A |
| EPS Diluted Total Ops | -24.30 | -61.30 | -439.50 | 41.72 | N/A |
| EPS Diluted Continuous Ops | -24.28 | -61.32 | -439.52 | 41.72 | N/A |
| EPS Diluted Before Non-Recurring Items | -24.30 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-52,148 | $-33,211 | $-14,176 | $7,194 | $N/A |